Precigen, Inc. Files Q1 2025 10-Q Report
Ticker: PGEN · Form: 10-Q · Filed: May 14, 2025 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Precigen's Q1 2025 10-Q is in: check financials for product/service segment performance.
AI Summary
Precigen, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results for the first quarter of 2025, detailing revenues and expenses across its product and service segments. Key financial data and operational updates are provided for the period.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational details for Precigen, Inc. during the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information which can reveal significant performance trends or challenges for the company.
Key Players & Entities
- PRECIGEN, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- INTREXON CORP (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, meaning the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20250514.
What was Precigen, Inc.'s former company name?
Precigen, Inc.'s former company name was INTREXON CORP.
What is Precigen, Inc.'s primary industry classification?
Precigen, Inc.'s Standard Industrial Classification is Pharmaceutical Preparations [2834].
What are the main business segments reported by Precigen, Inc.?
The filing indicates reporting for 'Product' and 'Service' segments, as well as 'Other'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding PRECIGEN, INC. (PGEN).